Michael C. Regan

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Development and characterization of functional antibodies targeting NMDA receptors”.

Development and characterization of functional antibodies targeting NMDA receptors

Nature Communications(2022)10.1038/s41467-022-28559-3

N/A

0DataRank · unranked

31 citations

Noriko Simorowski, Remy A. Yovanno, Michael C. Regan, Kevin Michalski, Ricardo Gómez +3 more

Novel GluN2B-Selective NMDA Receptor Negative Allosteric Modulator Possesses Intrinsic Analgesic Properties and Enhances Analgesia of Morphine in a Rodent Tail Flick Pain Model

ACS Chemical Neuroscience(2023)10.1021/acschemneuro.2c00779

N/A

0DataRank · unranked

16 citations

Michael C. Regan, Scott J. Myers, Kelsey A. Nocilla, Nicholas S. Akins, Yesim A. Tahirovic +6 more

Inhibition of GluN2B-containing N -methyl- D- aspartate receptors by radiprodil

Brain(2025)10.1093/brain/awaf355

N/A

0DataRank · unranked

2 citations

Michael C. Regan, Riley E. Perszyk, Lu Zhang, Hao Xing, Jiahui Chen +22 more